Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adriano Lazzarin

Showing results (11-20 of 328) with videos related to

Pageof 33
Sort By:
The New Microbiologica|July 11, 2007
Antiviral activity and clinical efficacy of atazanavir in HIV-1-infected patients: a reviewNicola Gianotti, Alessandro Soria, Adriano Lazzarin
Journal of Clinical Microbiology|June 7, 2003
Detection of Pneumocystis carinii and characterization of mutations associated with sulfa resistance in bronchoalveolar lavage samples from human immunodeficiency virus-infected subjectsAnna Zingale, Paola Carrera, Adriano Lazzarin, et al.
Drugs|May 17, 2005
The appealing story of HIV entry inhibitors : from discovery of biological mechanisms to drug developmentAntonella Castagna, Priscilla Biswas, Alberto Beretta, et al.
Seminars in Neurology|April 10, 2014
Central nervous system HIV infection in "less-drug regimen" antiretroviral therapy simplification strategiesFrancesca Ferretti, Nicola Gianotti, Adriano Lazzarin, et al.
The New Microbiologica|April 23, 2009
Improvement of CXCR3 ligand CXCL11/I-TAC measurement in human plasma and serumViviana Cremasco, Barbara Mantelli, Adriano Lazzarin, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 19, 2008
Recombinant human growth hormone: rationale for use in the treatment of HIV-associated lipodystrophyStefano Benedini, Ileana Terruzzi, Adriano Lazzarin, et al.
The New Microbiologica|May 28, 2015
HEFFICON: HIV Effectiveness Italian ConferenceAndrea Antinori, Massimo Andreoni, Carlo Federico Perno, et al.
Expert Opinion on Investigational Drugs|April 26, 2006
Oral CCR5 inhibitors: will they make it through?Priscilla Biswas, Silvia Nozza, Gabriella Scarlatti, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 11, 2006
The effects of the Roche AMPLICOR HIV-1 MONITOR UltraSensitive Test versions 1.0 and 1.5 viral load assays and plasma collection tube type on determination of response to antiretroviral therapy and the inappropriateness of cross-study comparisonsMichael Giordano, Thomas Kelleher, Richard J Colonno, et al.
HIV Clinical Trials|April 19, 2012
Safety profile of maraviroc in patients coinfected with HIV-1 and hepatitis B or C included in the maraviroc expanded access programAdriano Lazzarin, Soe Than, Srinivas R Valluri, et al.
Pageof 33

Showing results (11-20 of 328) with videos related to

Sort By:
Pageof 33
The New Microbiologica|July 11, 2007
Antiviral activity and clinical efficacy of atazanavir in HIV-1-infected patients: a reviewNicola Gianotti, Alessandro Soria, Adriano Lazzarin
Journal of Clinical Microbiology|June 7, 2003
Detection of Pneumocystis carinii and characterization of mutations associated with sulfa resistance in bronchoalveolar lavage samples from human immunodeficiency virus-infected subjectsAnna Zingale, Paola Carrera, Adriano Lazzarin, et al.
Drugs|May 17, 2005
The appealing story of HIV entry inhibitors : from discovery of biological mechanisms to drug developmentAntonella Castagna, Priscilla Biswas, Alberto Beretta, et al.
Seminars in Neurology|April 10, 2014
Central nervous system HIV infection in "less-drug regimen" antiretroviral therapy simplification strategiesFrancesca Ferretti, Nicola Gianotti, Adriano Lazzarin, et al.
The New Microbiologica|April 23, 2009
Improvement of CXCR3 ligand CXCL11/I-TAC measurement in human plasma and serumViviana Cremasco, Barbara Mantelli, Adriano Lazzarin, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 19, 2008
Recombinant human growth hormone: rationale for use in the treatment of HIV-associated lipodystrophyStefano Benedini, Ileana Terruzzi, Adriano Lazzarin, et al.
The New Microbiologica|May 28, 2015
HEFFICON: HIV Effectiveness Italian ConferenceAndrea Antinori, Massimo Andreoni, Carlo Federico Perno, et al.
Expert Opinion on Investigational Drugs|April 26, 2006
Oral CCR5 inhibitors: will they make it through?Priscilla Biswas, Silvia Nozza, Gabriella Scarlatti, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 11, 2006
The effects of the Roche AMPLICOR HIV-1 MONITOR UltraSensitive Test versions 1.0 and 1.5 viral load assays and plasma collection tube type on determination of response to antiretroviral therapy and the inappropriateness of cross-study comparisonsMichael Giordano, Thomas Kelleher, Richard J Colonno, et al.
HIV Clinical Trials|April 19, 2012
Safety profile of maraviroc in patients coinfected with HIV-1 and hepatitis B or C included in the maraviroc expanded access programAdriano Lazzarin, Soe Than, Srinivas R Valluri, et al.
Pageof 33